- Linguamatics I2E provides knowledge discovery capabilities to inform
81qd's health care consultancy services - Multi-year collaboration for NLP-based literature search and mining
CAMBRIDGE, England, and NEW YORK, Jan. 17 /PRNewswire/ -- Linguamatics Ltd, the leader in natural language processing (NLP) for life science research, and 81qd, the New York City-based health care technology consultancy, an affiliate of the Medical Knowledge Group (MKG), announce a multi-year collaboration to provide state-of-the-art product life cycle management consulting services. Central to the collaboration is the use of Linguamatics' flagship I2E software to identify and leverage business-critical insights for 81qd's clients. Applications include message mapping and opinion leader network analyses for the medical, health care, pharmaceutical, biotechnology, and life sciences fields. Financial details of the agreement were not disclosed.
"We evaluated other well known NLP-based technologies, but Linguamatics was the clear choice in terms of functionality and flexibility to support our business needs," said Aafia Chaudhry, MD, President, 81qd. "This new collaboration provides us with unrivalled capabilities in data analysis, synthesis and reporting to support our clients' unique needs. I2E's precision, accuracy and scalability are essential for developing our services in key opinion leadership sciences, physician sentiment analyses, and competitive intelligence reporting."
"81qd uniquely combines strong medical expertise with a clear vision of how to use our leading edge technology to accelerate and optimize critical life cycle management decisions in the clinical practice setting," said Roger Hale, COO and Co-founder of Linguamatics. "Our extended collaboration is an exciting step for Linguamatics, underlining our ability to impact decision- making across the pharmaceutical industry from bench to business."
ABOUT LINGUAMATICS L
|SOURCE Linguamatics Ltd|
Copyright©2008 PR Newswire.
All rights reserved